MedPage Today (2/27, George) reports, “Sparks of visual artistic creativity occurred early in frontotemporal dementia and were disproportionately observed in patients with temporal lobe-predominant degeneration, a case-control study showed.” The “burst of visual art expression was associated with damage to brain regions that normally suppress dorsomedial occipital cortex function, reported” researchers. The findings of the 17-patient study were published online in JAMA Neurology.

Related Links:

— MedPage Today (requires login and subscription)

The AP (2/24, Seitz, Whitehurst) reported that on Friday, the Biden Administration “moved…to require patients see a doctor in person before getting attention deficit disorder medication or addictive painkillers, toughening access to the drugs against the backdrop of a deepening opioid crisis.” The Drug Enforcement Administration “said late Friday it plans to reinstate once longstanding federal requirements for powerful drugs that were waived once COVID-19 hit.” The AP added, “Patients will still be able to get common prescriptions like antibiotics, skin creams, birth control and insulin prescribed through telehealth visits.”

CNN (2/25, Millman) reported, “Prescriptions for other drugs – to help with pain or sleep, for example – could be prescribed via telehealth but a patient would need an in-person evaluation before obtaining a refill,” while Schedule II medications “necessitate an in-person appointment before any prescription can be written.”

Related Links:

— “Feds seek to limit telehealth prescriptions for some drugs “Amanda Seitz and Lindsay Whitehurst, AP, February 24, 2023

Psychiatric News (2/24) reported “youth with anxiety disorders who contract COVID-19 may experience worsening anxiety symptoms,” according to an “analysis on data obtained from 26 patients” from a “longitudinal study.” Researchers “found that post-COVID-19, patients’ anxiety symptoms were significantly worse on all” Generalized Anxiety Disorder-7 “subscales (including feelings of nervousness, irritability, and dread) and the” Clinical Global Impression-Severity scale. The results were published online Feb. 21 in an empirical letter to the editor in the Journal of the American Academy of Child & Adolescent Psychiatry.

Related Links:

— “Youth With Anxiety May Experience Worsening Symptoms After COVID-19, Psychiatric News, February 24, 2023

The New York Times (2/26, Span) reports, “Anxiety is the most common mental health disorder; a 2017 study of older adults in six countries found that more than 17 percent had experienced an anxiety disorder within the past year.” And “recently, attention to anxiety has increased because of a draft recommendation from the United States Preventive Services Task Force” urging greater screening for anxiety among adults. One author of an “editorial on late-life anxiety in JAMA Psychiatry” said, “With a common disorder that causes a lot of impairment of quality of life and that has simple, inexpensive, straightforward kinds of treatment, I think screening is called for.”

Related Links:

— “Why Aren’t Doctors Screening Older Americans for Anxiety? “Paula Span, The New York Times, February 26, 2023

The Washington Post (2/23, J Sima) reports, “Inflammation in the body may be triggering or exacerbating depression in the brains of some patients,” with clinical data suggesting that “targeting and treating the inflammation may be a way to provide more-precise care.” According to the Post, “it appears that inflammatory agents in the blood can break down the barrier between the body and the brain, causing neuroinflammation and altering key neural circuits, researchers say,” and “in people at risk for depression, inflammation may be a trigger for the disorder.” The article goes on to summarize recent studies exploring how inflammation appears to be a “pathway to depression.”

Related Links:

— “The Washington Post (requires login and subscription)